Qiagen N.V. Downgraded by TheStreet to “Hold” (QGEN)
Qiagen N.V. (NASDAQ:QGEN) was downgraded by analysts at TheStreet from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Monday, StockRatingsNetwork.com reports.
The analysts wrote, “Qiagen (QGEN) has been downgraded by TheStreet Ratings from buy to hold. The company’s strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow.”
Several other analysts have also recently commented on the stock. Analysts at BNP Paribas downgraded shares of Qiagen N.V. from a “neutral” rating to an “underperform” rating in a research note to investors on Friday, October 4th. Separately, analysts at Morgan Stanley initiated coverage on shares of Qiagen N.V. in a research note to investors on Friday, September 6th. They set an “equal weight” rating on the stock. Finally, analysts at Janney Montgomery Scott initiated coverage on shares of Qiagen N.V. in a research note to investors on Thursday, August 15th. They set a “neutral” rating on the stock. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $21.58.
Shares of Qiagen N.V. (NASDAQ:QGEN) traded down 0.64% on Monday, hitting $20.885. The stock had a trading volume of 485,323 shares. Qiagen N.V. has a 1-year low of $16.98 and a 1-year high of $22.20. The stock’s 50-day moving average is $21.07 and its 200-day moving average is $20.2. The company has a market cap of $4.894 billion and a price-to-earnings ratio of 142.99.
Qiagen N.V. (NASDAQ:QGEN) last released its earnings data on Tuesday, July 30th. The company reported $0.27 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.24 by $0.03. The company had revenue of $316.40 million for the quarter, compared to the consensus estimate of $311.75 million. During the same quarter in the prior year, the company posted $0.25 earnings per share. The company’s quarterly revenue was up 3.0% on a year-over-year basis. Analysts expect that Qiagen N.V. will post $1.03 EPS for the current fiscal year.
QIAGEN N.V., (NASDAQ:QGEN) is a holding company, which provides sample and assay technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.